Quantcast
Home > Quotes > EIGR

Eiger BioPharmaceuticals, Inc. Common Stock (EIGR) Quote & Summary Data

EIGR 
$11.44
*  
0.24
2.05%
Get EIGR Alerts
*Delayed - data as of Dec. 7, 2018  -  Find a broker to begin trading EIGR now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    EIGR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 11.86 / $ 11.11
Share Volume
126,368
50 Day Avg. Daily Volume
141,188
Previous Close
$ 11.68
52 Week High / Low
$ 18 / $ 7.46
Market Cap
218,452,817
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
126,368
50 Day Avg. Daily Volume:
141,188

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -3.97

Trading Range

The current last sale of $11.44 is 53.35% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 11.86 $ 18
 Low: $ 11.11 $ 7.46

Company Description (as filed with the SEC)

On March 22, 2016, Celladon Corporation, or Celladon, and privately-held Eiger BioPharmaceuticals, Inc., or Private Eiger, completed a business combination in accordance with the terms of the Agreement and Plan of Merger and Reorganization, or the Merger Agreement, dated as of November 18, 2015, by and among Celladon, Celladon Merger Sub, Inc., a wholly-owned subsidiary of Celladon, or Merger Sub, and Private Eiger, pursuant to which Merger Sub merged with and into Private Eiger, with Private Eiger surviving as a wholly-owned subsidiary of Celladon. This transaction is referred to herein as "the Merger." Immediately following the Merger, Celladon changed its name to "Eiger BioPharmaceuticals, Inc." In connection with the closing of the Merger, our common stock began trading on The NASDAQ Global Market under the ticker symbol "EIGR" on March 23, 2016.  ... More ...  


Risk Grade

Where does EIGR fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 11.73
Open Date:
Dec. 7, 2018
Close Price:
$ 11.44
Close Date:
Dec. 7, 2018

Consensus Recommendation

Analyst Info